Literature DB >> 9857875

Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy.

N Yoshida1, H Ikeda, T Wada, A Matsumoto, S Maki, A Muro, A Shibata, T Imaizumi.   

Abstract

OBJECTIVES: We examined by thallium-201 scintigraphy whether exercise-induced abnormal blood pressure response (BPR) is related to myocardial ischemia.
BACKGROUND: Hemodynamic instabilities during exercise in patients with hypertrophic cardiomyopathy (HCM) are considered to be caused by abnormal reflex control of vascular resistance.
METHODS: In 105 patients with HCM, exercise thallium scintigraphy was performed by means of a multistage, symptom-limited bicycle ergometer exercise test.
RESULTS: Eighty-eight patients had normal BPR (> or = 25 mm Hg from baseline to peak exercise), and 17 had abnormal BPR (<25 mm Hg). Clinical characteristics including age, the prevalence of obstruction, New York Heart Association functional class and echocardiographic measurements were similar between the two groups. Left ventricular end-diastolic pressure was significantly higher in patients with abnormal BPR than in those with normal BPR (18+/-8 vs. 14+/-5 mm Hg, p < 0.05). Exercise-induced perfusion abnormalities including fixed and reversible perfusion defects, and left ventricular cavity dilatation (LVCD) were identified in 72 (69%) of 105 study patients. Left ventricular cavity dilatation indicates subendocardial hypoperfusion and is a marker of diffuse subendocardial ischemia. The prevalence of fixed or reversible perfusion defects was similar between the two groups. Patients with abnormal BPR had the higher prevalence of LVCD as compared to those with normal BPR (47.1 vs. 10%, p < 0.0002). Multiple logistic regression analysis revealed that LVCD was independently associated with abnormal BPR (odds ratio 3.76, 95% confidence interval 1.61 to 8.76).
CONCLUSIONS: Exercise-induced abnormal BPRs in patients with HCM are related to subendocardial ischemia during exercise.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857875     DOI: 10.1016/s0735-1097(98)00498-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

Review 1.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

2.  Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.

Authors:  Kevin S Heffernan; Martin S Maron; Eshan A Patvardhan; Richard H Karas; Jeffrey T Kuvin
Journal:  Am J Cardiol       Date:  2010-12-22       Impact factor: 2.778

3.  Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy.

Authors:  Satoshi Kaimoto; Tatsuya Kawasaki; Toshiro Kuribayashi; Michiyo Yamano; Shigeyuki Miki; Tadaaki Kamitani; Hiroaki Matsubara
Journal:  Int J Cardiovasc Imaging       Date:  2011-12-21       Impact factor: 2.357

Review 4.  Myocardial ischemia in patients with diastolic dysfunction and heart failure.

Authors:  Thomas E Vanhecke; Robert Kim; Shaheena Z Raheem; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

5.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

6.  Clinical use of nuclear cardiology in the assessment of heart failure.

Authors:  Shinro Matsuo; Kenichi Nakajima; Seigo Kinuya
Journal:  World J Cardiol       Date:  2010-10-26

7.  Cardiac magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Milind Y Desai; Ashwat Dhillon; Andrew C Y To
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

8.  Vagal enhancement linking abnormal blood pressure response and subendocardial ischemia in hypertrophic cardiomyopathy.

Authors:  Tatsuya Kawasaki; Hiroki Sugihara
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09-09       Impact factor: 1.468

9.  Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy.

Authors:  Quirino Ciampi; Sandro Betocchi; Maria Angela Losi; Adele Ferro; Alberto Cuocolo; Raffaella Lombardi; Bruno Villari; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

10.  Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy.

Authors:  X Jouven; A Hagege; P Charron; L Carrier; O Dubourg; J M Langlard; S Aliaga; J B Bouhour; K Schwartz; M Desnos; M Komajda
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.